Cargando…

Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study

BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enteroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Junior, Moacyr S, Correa, Luci, Marra, Alexandre R, Camargo, Luis FA, Pereira, Carlos AP
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014772/
https://www.ncbi.nlm.nih.gov/pubmed/17678541
http://dx.doi.org/10.1186/1471-2334-7-88
_version_ 1782136564693860352
author Junior, Moacyr S
Correa, Luci
Marra, Alexandre R
Camargo, Luis FA
Pereira, Carlos AP
author_facet Junior, Moacyr S
Correa, Luci
Marra, Alexandre R
Camargo, Luis FA
Pereira, Carlos AP
author_sort Junior, Moacyr S
collection PubMed
description BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enterococci). The aim of this work was to analyze the use of vancomycin and the risk factors associated with inappropriate treatment. METHODS: A prospective survey was conducted on all patients receiving vancomycin between 1(st )March 2002 and 30(th )September 2002 in a university-school hospital. Appropriateness of vancomycin use was assessed, according to the criteria established by the Centers for Disease Control and Prevention (CDC), at two time points: first, at the beginning of therapy, and second, continuing after 72 hours. RESULTS: A total of 557 patients received vancomycin. Three hundred seventy-four (67.1%) were under 60 years old, 374 (67.1%) had prolonged stays (>two weeks) in hospital, and 455 (81.7%) were in the intensive care unit (ICU). Two hundred sixty-three patients (47.2%) had some invasive device. In 324 (58.2%) patients the duration of vancomycin treatment was up to two weeks. Vancomycin was inappropriately used in 65.7% during the first 24 hours and in 67% at the 72 hours point according to CDC criteria [4]. The inappropriateness of vancomycin use during the first 24 hours was related to: patients aged less than 60 (OR 1.7; CI 95% 1.1–2.5), non-ICU patients (OR 1.5; CI 95% 1.0–2.4) and patients without neutropenia (OR 7.5; CI 95% 2.4–22.7). At 72 hours, the inappropriateness of vancomycin use was related to: patients aged less than 60 (OR 1.5; CI 95% 1.0–2.3), non-ICU patients (OR 1.7; CI 95% 1.1–2.7) and patients without neutropenia (OR 8.0; CI 95% 2.6–24.3). CONCLUSION: Vancomycin was abused. Patients aged less than 60, non-ICU patients and those who did not present neutropenia were the principal groups at risk of inappropriate use.
format Text
id pubmed-2014772
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20147722007-10-11 Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study Junior, Moacyr S Correa, Luci Marra, Alexandre R Camargo, Luis FA Pereira, Carlos AP BMC Infect Dis Research Article BACKGROUND: Vancomycin use is considered inappropriate in most hospitals. A particular concern is the recent emergence of S. aureus with decreased susceptibility to vancomycin, making it important to reduce overall exposure to vancomycin to minimize the incidence of VRE (vancomycin-resistant enterococci). The aim of this work was to analyze the use of vancomycin and the risk factors associated with inappropriate treatment. METHODS: A prospective survey was conducted on all patients receiving vancomycin between 1(st )March 2002 and 30(th )September 2002 in a university-school hospital. Appropriateness of vancomycin use was assessed, according to the criteria established by the Centers for Disease Control and Prevention (CDC), at two time points: first, at the beginning of therapy, and second, continuing after 72 hours. RESULTS: A total of 557 patients received vancomycin. Three hundred seventy-four (67.1%) were under 60 years old, 374 (67.1%) had prolonged stays (>two weeks) in hospital, and 455 (81.7%) were in the intensive care unit (ICU). Two hundred sixty-three patients (47.2%) had some invasive device. In 324 (58.2%) patients the duration of vancomycin treatment was up to two weeks. Vancomycin was inappropriately used in 65.7% during the first 24 hours and in 67% at the 72 hours point according to CDC criteria [4]. The inappropriateness of vancomycin use during the first 24 hours was related to: patients aged less than 60 (OR 1.7; CI 95% 1.1–2.5), non-ICU patients (OR 1.5; CI 95% 1.0–2.4) and patients without neutropenia (OR 7.5; CI 95% 2.4–22.7). At 72 hours, the inappropriateness of vancomycin use was related to: patients aged less than 60 (OR 1.5; CI 95% 1.0–2.3), non-ICU patients (OR 1.7; CI 95% 1.1–2.7) and patients without neutropenia (OR 8.0; CI 95% 2.6–24.3). CONCLUSION: Vancomycin was abused. Patients aged less than 60, non-ICU patients and those who did not present neutropenia were the principal groups at risk of inappropriate use. BioMed Central 2007-08-01 /pmc/articles/PMC2014772/ /pubmed/17678541 http://dx.doi.org/10.1186/1471-2334-7-88 Text en Copyright © 2007 Junior et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Junior, Moacyr S
Correa, Luci
Marra, Alexandre R
Camargo, Luis FA
Pereira, Carlos AP
Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title_full Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title_fullStr Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title_full_unstemmed Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title_short Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
title_sort analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014772/
https://www.ncbi.nlm.nih.gov/pubmed/17678541
http://dx.doi.org/10.1186/1471-2334-7-88
work_keys_str_mv AT juniormoacyrs analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy
AT correaluci analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy
AT marraalexandrer analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy
AT camargoluisfa analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy
AT pereiracarlosap analysisofvancomycinuseandassociatedriskfactorsinauniversityteachinghospitalaprospectivecohortstudy